Article Details

Bajaj Healthcare zooms 20% as Co seeks compulsory licence for Baricitinib

Retrieved on: 2021-06-29 05:15:00

Tags for this article:

Click the tags to see associated articles and topics

Bajaj Healthcare zooms 20% as Co seeks compulsory licence for Baricitinib. View article details on hiswai:

Excerpt

EUA permits the emergency use of baricitinib, in combination with remdesivir, for treatment of suspected or laboratory confirmed COVID-19 in ...

Article found on: www.business-standard.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up